(Q44608577)

4 December 2017

title

ATG versus basiliximab induction therapy in renal allograft recipients receiving a dual immunosuppressive regimen: one-year results (English)

1 reference

recombinant fusion proteins

4 December 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00679-1

18 March 2024

5

P. Reinke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

author name string

S. G. Tullius

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

J. Pratschke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

V. Strobelt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

A. Kahl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

G. May

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

U. Frei

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

P. Neuhaus

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14529854

18 March 2024

language of work or name

English

0 references

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0041134503006791?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00679-1

https://api.elsevier.com/content/article/PII:S0041134503006791?httpAccept=text/plain

18 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00679-1

Transplantation Proceedings

18 March 2024

published in

1 reference

4 December 2017

volume

35

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

2100-2101

1 reference

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900679-1

7 January 2021

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900679-1

7 January 2021

Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900679-1

7 January 2021

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900679-1

7 January 2021

Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900679-1

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference